Application Nr Approved Date Route Status External Links
ANDA209686 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Clonidine Hydrochloride Extended-Release Is Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications [See Clinical Studies ( 14 )] . Clonidine Hydrochloride Extended-Release Tablets Are A Centrally Acting Alpha 2 -Adrenergic Agonist Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy Or As Adjunctive Therapy To Stimulant Medications. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Clonidine Hydrochloride CLONIDINE HYDROCHLORIDE ZINC896484

Comments